Thyroxine as a Pleiotropic Modulator in ADPKD: Insights from Engineered Tubules, In Vivo Models, and Patients

Angelo Michele Lavecchia; Matias Trillini; Laura Locatelli; A Del Vecchio; Domenico Cerullo; Alessandro Villa; Tobia Peracchi; Valerio Brizi; Sara Buttò; Daniela Corna; Nadia Rubis; Chiara Guarinoni; Giuseppe Remuzzi; Christodoulos Xinaris

doi:10.1681/asn.20253sq0251w

Related publications

Article2008

In Vivo Effects and Ex Vivo Characteristics Following Implantation of a Tissue Engineered Urethral Wrap

Donna J. Haworth, Minoru Miyazato, Akira Furuta, Dae Kyung Kim, Douglas W. Chew, Naoki Yoshimura, Michael B. Chancellor, David Vorp

Article2007

Adiponectin as a modulator of hepatic fibrosis in chronic HCV-Infection

Inga Wedemeyer, K Petmecky, Uta Drebber, E Kühnen, S Mohren, Ralf Weiskirchen, Ali Canbay, M Odenthal, HP Dienes

Article2007

Adiponectin as a putative modulator of hepatitis in chronic HCV-infection

Inga Wedemeyer, K Petmecky, Uta Drebber, E Kühnen, S Mohren, Ralf Weiskirchen, Ali Canbay, M Odenthal, HP Dienes

Article2012

Measuring and Estimating GFR and Treatment Effect in ADPKD Patients: Results and Implications of a Longitudinal Cohort Study

Piero Ruggenenti, Flavio Gaspari, Antonio Cannatà, Fabiola Carrara, Claudia Cella, Silvia Ferrari, Nadia Stucchi, Silvia Prandini, Bogdan Ene‐Iordache, Olimpia Diadei, Norberto Perico, Patrizia Ondei, Antonio Pisani, Erasmo Buongiorno, Piergiorgio Messa, Mauro Dugo, Giuseppe Remuzzi

Article2010

Differential In Vivo Effects on Target Pathways of a Novel Arylpyrazole Glucocorticoid Receptor Modulator Compared with Prednisolone

Donald J. Roohk, Krista A Varady, Scott Turner, Claire Emson, Richard W. Gelling, Mahalakshmi Shankaran, Glen Lindwall, Lauren E. Shipp, Thomas S. Scanlan, Jen-Chywan Wang, Marc Hellerstein